BOT botanix pharmaceuticals ltd
Add to My Watchlist 2.27% ! 2.2¢

Positive for BOT, page-34

  1. Sidsuss
    73 Posts.
    lightbulb Created with Sketch.  5
    clock Created with Sketch.
    29/03/18
    01:10
    Post #: 32103922
    I should of said FDA approval instead of phase 2. It is mentioned in the investor presentation on page 7 where it outlines the potential to monetise on its products before achieving FDA approval. On the same page it has a graph which references many recent dermatology transactions whereby the majority of the transacted products being in phase II.
    BOT Price at posting: 11.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Tivan agrees to project finance mandate for Speewah fluorite project
right-arrow Created with Sketch.
NEWS Resmed turns in record fourth quarter revenue of US$1.5B
right-arrow Created with Sketch.
NEWS AVITA Medical raises 2026 outlook after record second quarter
right-arrow Created with Sketch.
NEWS Want to reach millions of investors? Get in touch
right-arrow Created with Sketch.
NEWS Read the Latest ASX News here on HotCopper
right-arrow Created with Sketch.
NEWS HotCopper Highlights, Week 32: Rare earths, lithium, and gas dominate conversations
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
Start T rading
Last
2.2¢ 		Change
-0.001(2.27%) 		Mkt cap ! $60.15M
Open High Low Volume
2.3¢ 2.3¢ 2.1¢ 5.306M

Buyers (Bids)

Vol. Price($)
3806825 2.1¢
 

Sellers (Offers)

Price($) Vol.
2.2¢ 1162645
Last trade - 16.10pm 13/08/2026 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.